Search
for

    Sort by

    Research 631–660 of 1000+

    1. 5α‐Reductase inhibitors and prostatic disease Clinical endocrinology · 1994 · 21 citations
    2. Chronic toxicity of 3,4,3′,4′-tetrachlorobiphenyl in the marmoset monkey (Callithrix jacchus) Toxicology · 1988 · 21 citations
    3. Endocrinology of Hirsutism: From Androgens to Androgen Excess Disorders Frontiers of Hormone Research · 2019 · 20 citations
    4. Recent Advances in the Chemistry and Pharmacological Activity of New Steroidal Antiandrogens and 5α-Reductase Inhibitors Current Medicinal Chemistry · 2005 · 20 citations
    5. Comparison of clinical trials with finasteride and dutasteride. PubMed · 2004 · 20 citations
    6. Novel inhibitors of 5α-reductase Expert Opinion on Therapeutic Patents · 2002 · 20 citations
    7. Synthesis of phenanthridin-3-one derivatives: Non-steroidal inhibitors of steroid 5-α-reductase Tetrahedron Letters · 1995 · 20 citations
    8. Repeated finasteride administration induces depression-like behavior in adult male rats Behavioural Brain Research · 2019 · 19 citations
    9. Evaluation and Treatment of Hirsutism in Premenopausal Women JAMA · 2018 · 19 citations
    10. Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism The obstetrician & gynaecologist · 2013 · 19 citations
    11. Skin Barrier Dysfunction in Acne Vulgaris: Pathogenesis and Therapeutic Approaches Medical Science Monitor · 2024 · 18 citations
    12. Difficult and rare forms of acne Clinics in Dermatology · 2016 · 18 citations
    13. Connexin 30, a new marker of hyperproliferative epidermis British Journal of Dermatology · 2006 · 18 citations
    14. Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It’s Time to Sound the Alarm The World Journal of Men's Health · 2020 · 17 citations
    15. 5α-Reductase Inhibitors, Chemical and Clinical Models Steroids · 1998 · 17 citations
    16. FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects The Journal of Steroid Biochemistry and Molecular Biology · 1996 · 17 citations
    17. MANAGEMENT OF ENDOCRINE DISEASE Hyperandrogenic states in women: pitfalls in laboratory diagnosis European Journal of Endocrinology · 2018 · 16 citations
    18. Safety aspects of androgen treatment with 5α-dihydrotestosterone Andrologia · 2007 · 16 citations
    19. Therapeutic Androgen Receptor Ligands Nuclear Receptor Signaling · 2003 · 16 citations
    20. The beneficial effects of Pumpkin (<i>Cucurbita pepo</i>L.) seed oil for health condition of men Food Reviews International · 2018 · 15 citations
    21. Development of optimized self-nanoemulsifying lyophilized tablets (SNELTs) to improve finasteride clinical pharmacokinetic behavior Drug Development and Industrial Pharmacy · 2017 · 15 citations
    22. 5α-Reductase Inhibitors (5ARIs) and Male Reproduction Advances in Experimental Medicine and Biology · 2017 · 15 citations
    23. 5-Alpha-Reductase Inhibitors and Combination Therapy Urologic Clinics of North America · 2016 · 15 citations
    24. Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs Pharmacopsychiatry · 2015 · 15 citations
    25. 5α-Reductase inhibitors alter steroid metabolism and may contribute to insulin resistance, diabetes, metabolic syndrome and vascular disease: a medical hypothesis Hormone Molecular Biology and Clinical Investigation · 2014 · 15 citations
    26. Inhibition of steroid 5 alpha-reductase with finasteride: sleep-related erections, potency, and libido in healthy men. The Journal of Clinical Endocrinology and Metabolism · 1995 · 15 citations
    27. Approach to androgen excess in women: Clinical and biochemical insights Clinical Endocrinology · 2022 · 14 citations
    28. Fixed-dose combination PRO 160/120 of sabal and urtica extracts improves nocturia in men with LUTS suggestive of BPH: re-evaluation of four controlled clinical studies World Journal of Urology · 2014 · 14 citations
    29. Hyperandrogenism in Adolescent Girls Endocrine development · 2012 · 14 citations
    30. New ester derivatives of dehydroepiandrosterone as 5α-reductase inhibitors Steroids · 2011 · 14 citations